Abstract
Objectives
To compare short- and long-term local tissue reaction of polyacrylate polyalcohol copolymer (PPC) with dextranomer/hyaluronic acid (DHA) in rabbits.
Methods
Eight healthy New Zealand rabbits were randomly divided into two groups. In group I (control group), DHA was injected just beneath the mucosal layer of the bladder wall, while PPC was injected in group II. Subcutaneous injection of both bulking agents was also performed in nude mice. Histological evaluations with leukocyte common antibody (LCA), CD68, CD31, and CD34 were conducted on biopsies 1 and 6 months postoperatively. Scanning electron microscopy (SEM) and MTT assay were also performed for these two bulking agents.
Results
SEM images revealed larger particle size of PPC. LCA and CD68 staining was significantly higher in group II as compared with group I in both short- and long-term follow-ups. However, in groups I and II, expression of CD31 (101 ± 0.5 vs. 92 ± 0.25, p > 0.05) and CD34 (115 ± 0.75 vs. 103 ± 0.5, p > 0.05) was not significantly different in long-term follow-up. Remarkably, severe fibrosis was observed in group II as compared to mild fibrosis in group I one month after injection. The results of in vivo application of these bulking agents in nude mice were in accordance with the results obtained from rabbit model. MTT assay revealed that cell proliferation was significantly higher in the presence of DHA as compared with PPC.
Conclusion
Severe inflammation and fibrosis in PPC may be due to continued foreign body reaction, presence of alcohol polymers, or larger particle sizes.
Similar content being viewed by others
Abbreviations
- LCA:
-
Leukocyte common antigen
- VUR:
-
Vesicoureteral reflux
- PPC:
-
Polyacrylate polyalcohol copolymer
- DHA:
-
Dextranomer/hyaluronic acid
References
Matouschek E (1981) Treatment of vesicorenal reflux by transurethral teflon-injection (author’s transl). Der Urologe Ausg A 20(5):263–264
O’Donnell B, Puri P (1984) Treatment of vesicoureteric reflux by endoscopic injection of Teflon. J urol 167(4):1808–1809
De Vocht TF, Chrzan R, Dik P, Klijn AJ, De Jong TP (2010) Long-term results of bulking agent injection for persistent incontinence in cases of neurogenic bladder dysfunction. J Urol 183(2):719–723. doi:10.1016/j.juro.2009.10.044
Chertin B, Kocherov S (2010) Long-term results of endoscopic treatment of vesicoureteric reflux with different tissue-augmenting substances. J Pediatr Urol 6(3):251–256. doi:10.1016/j.jpurol.2009.10.011
Chertin B, Puri P (2002) Endoscopic management of vesicoureteral reflux: does it stand the test of time? Eur Urol 42(6):598–606
Malizia AA Jr, Reiman HM, Myers RP, Sande JR, Barham SS, Benson RC Jr, Dewanjee MK, Utz WJ (1984) Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251(24):3277–3281
Ormaechea M, Ruiz E, Denes E, Gimenez F, Denes FT, Moldes J, Amarante A, Pioner G, Dekermacher S, de Badiola F (2010) New tissue bulking agent (polyacrylate polyalcohol) for treating vesicoureteral reflux: preliminary results in children. J Urol 183(2):714–717. doi:10.1016/j.juro.2009.10.047
Stenberg A, Lackgren G (1995) A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results. J Urol 154(2 Pt 2):800–803
Lightner D, Rovner E, Corcos J, Payne C, Brubaker L, Drutz H, Steinhoff G, Zuidex Study G (2009) Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology 74(4):771–775. doi:10.1016/j.urology.2009.05.034
Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC (2004) The modified sting procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171(6):2413–2416
Elder JS, Shah MB, Batiste LR, Eaddy M (2007) Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux. Curr Med Res Opin 23(Suppl 4 (S4)):S15–S20. doi:10.1185/030079907X226230
Caione P, Capozza N (2002) Endoscopic treatment of urinary incontinence in pediatric patients: 2-year experience with dextranomer/hyaluronic acid copolymer. J Urol 168(4 Pt 2):1868–1871
Stenberg A, Sundin A, Larsson B, Lackgren G, Stenberg A (1997) Lack of distant migration after injection of A sup 125 iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158(5):1937–1941
Stredele RJ, Dietz HG, Stehr M (2013) Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents. J Pediatr Urol 9(1):71–76. doi:10.1016/j.jpurol.2011.12.004
Moore K, Bolduc S (2014) Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux. J Urol 192(6):1794–1799. doi:10.1016/j.juro.2014.05.116
Ben-Meir D, Morgenstern S, Sivan B, Efrat R, Livne PM (2012) Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux. J Urol 188(1):258–261. doi:10.1016/j.juro.2012.03.019
Chertin B, Arafeh WA, Zeldin A, Kocherov S (2011) Preliminary data on endoscopic treatment of vesicoureteric reflux with polyacrylate polyalcohol copolymer (Vantris): surgical outcome following single injection. J Pediatr Urol 7(6):654–657
Chertin B, Arafeh WA, Zeldin A, Ostrovsky IA, Kocherov S (2013) Endoscopic correction of VUR using vantris as a new non-biodegradable tissue augmenting substance: three years of prospective follow-up. Urology 82(1):201–204
Sharifiaghdas F, Tajalli F, Otukesh H, Shamsabadi RH (2014) Endoscopic correction of primary VUR by using polyacrylate polyalcohol copolymer (Vantris) in young girls: 2-year follow-up. J Pediatr Urol 10(6):1032–1036. doi:10.1016/j.jpurol.2014.02.016
Kocherov S, Ulman I, Nikolaev S, Corbetta JP, Rudin Y, Slavkovic A, Dokumcu Z, Avanoglu A, Menovshchikova L, Kovarskiy S (2014) Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (vantris). Urology 84(3):689–693
Sencan A, Yildirim H, Ozkan KU, Ucan B, Hosgor M (2014) Open ureteroneocystostomy after failed endoscopic injection with three different bulking agents for the treatment of vesicoureteral reflux. J Pediatr Surg 49(11):1652–1655. doi:10.1016/j.jpedsurg.2014.04.012
Alizadeh F, Mazdak H, Khorrami MH, Khalighinejad P, Shoureshi P (2013) Postoperative ureteral obstruction after endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer (Vantris®). J Pediatr Urol 9(4):488–492
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors has direct or indirect commercial financial incentive associating with publishing the article and does not have any conflict of interest, and will sign the Disclosing Form.
Ethical approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
Rights and permissions
About this article
Cite this article
Kajbafzadeh, AM., Sabetkish, S., Khorramirouz, R. et al. Comparison of histopathological characteristics of polyacrylate polyalcohol copolymer with dextranomer/hyaluronic acid after injection beneath the bladder mucosa layer: a rabbit model. Int Urol Nephrol 49, 747–752 (2017). https://doi.org/10.1007/s11255-017-1540-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-017-1540-z